Fracture after cardiac transplantation: A prospective longitudinal study

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 5, 1996, Pages 1740-1746

  Shane, Elizabeth ^a   Rivas, Maria ^a,d   Staron, Ronald B ^a   Silverberg, Shonni J ^a   Seibel, Markus J ^c   Kuiper, Jan ^a,e   Mancini, Donna ^a   Addesso, Vicki ^a   Michler, R E ^a   Factor Litvak, P ^b  

^a The New York Presbyterian Hospital   (United States)

^b School of Public Health ^*  (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d VA MEDICAL CENTER   (Puerto Rico)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; AZATHIOPRINE; CALCITRIOL; CALCIUM CARBONATE; CYCLOSPORIN A; GLUCOCORTICOID; MULTIVITAMIN; OSTEOCALCIN; PARATHYROID HORMONE; PREDNISONE; PYRIDONE DERIVATIVE; VITAMIN D;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINERAL METABOLISM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR; SPINE RADIOGRAPHY; VERTEBRA FRACTURE;

BONE DENSITY; CYCLOSPORINE; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; OSTEOCALCIN; PARATHYROID HORMONE; PREDNISONE; PROSPECTIVE STUDIES; RISK FACTORS; SPINAL FRACTURES;

EID: 9344258565     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.5.1740     Document Type: Article

References (53)

1. Hosenpud JD, Novick RJ, Breen TJ, Fsily OP. 1994 The registry of the International Society for Heart and Lung Transplantation: eleventh official report-1994. J Heart Lung Transplant. 13:561-570.
2. Shane E, Rivas M, Silverberg SJ, et al. 1993 Osteoporosis after cardiac transplantation. Am J Med. 94:257-264.
3. Meys E, Terreaux-Duvert F, Beaume-Six T, Dureau G, Meunier PJ. 1993 Effects of calcium, calderol and monofluorophosphate on lumbar bone mass and parathyroid function in patients after cardiac transplantation. Osteoporosis Int. 3:329-332.
4. Muchmore JS, Cooper DKC, Ye Y, Schlegel VJ, Zudhi N. 1991 Loss of vertebral bone density in heart transplant patients. Transplant Proc. 23:1184-1185.
5. Rich GM, Mudge GH, Laffel GL, LeBoff MS. 1992 Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients. J Heart Lung Transplant. 11:950-958.
6. Lee AH, Mull RL, Keenan GF, et al. 1994 Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med. 96:35-41.
7. Rivas M, Kim TS, Staron RB, Bilezikian JP, Shane E. 1992 Bone loss and fractures occur within 6 months of heart transplantation [Abstract]. J Bone Miner Res. 7:358.
8. Rivas M, Silverberg SJ, Kim TS, Shane E. 1993 Femoral neck bone loss predominates one year after cardiac transplantation [Abstract]. J Bone Miner Res. 8:205.
9. Sambrook PN, Kelly PJ, Keogh A, et al. 1994 Bone loss after cardiac transplantation: a prospective study. J Heart Lung Transplant. 13:116-121.
10. Kleerekoper M, Avioli LV. 1993 Evaluation and treatment of postmenopausal osteoporosis. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. New York: Raven Press; 223-229.
11. Cummings SR, Black D. 1995 Bone mass measurements and risk of fracture in Caucasian women: a review of findings from prospective studies. Am J Med. 98(Suppl 2A):24-28.
12. Eastell R, Cedel SL, Wahner HW, Riggs BL, Melton III LJ. 1991 Classification of vertebral fractures. J Bone Miner Res. 6:207-215.
13. Delmas PD, Malaval L, Arlot M, Meunier PJ. 1985 Serum bone gla-protein compared to bone histomorphometry in endocrine disease. Bone. 6:329-341.
14. Gundberg CM, Wilson PS, Gallop PM, Parfitt AM. 1985 Determination of osteocalcin in human serum: results with two kits compared with those by a well-characterized assay. Clin Chem. 31:1720-1723.
15. Nussbaum SR, Zahradnik RJ, Lavigne JR, et al. 1987 Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 33:1364-1367.
16. Silverberg SJ, Shane E, de la Cruz L, et al. 1989 Skeletal disease in primary hyperparathyroidism. J Bone Miner Res. 4:283-291.
17. Seibel MJ, Robins SP, Bilezikian JP. 1992 Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab. 3:263-270.
18. Black D, Duncan A, Robins SP. 1989 Quantitative analysis of pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high performance liquid chromatography. Anal Biochem. 137:380-388.
19. Breslow NE, Day NE. 1980 Statistical methods in cancer research, vol 1. Lyon: International Agency for Research on Cancer.
20. Haagsma EB, Thijn CJP, Post JG, Slooff MJH, Gisp CH. 1988 Bone disease after liver transplantation. J Hepatol. 6:94-100.
21. Arnold JC, Hauser R, Ziegler R, et al. 1992 Bone disease after liver transplantation. Transplant Proc. 24:2709-2710.
22. McDonald JA, Dunstan CR, Dilworth P, et al. 1991 Bone loss after liver transplantation. Hepatology. 14:613-619.
23. Navasa M, Monegal A, Guanabens N, et al. 1994 Bone fractures in liver transplant patients. Br J Rheumatol. 33:52-55.
24. Eastell R, Dickson ER, Hodgson SF, et al. 1991 Rates of bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology. 14:296-300.
25. Meys E, Fontanges E, Fourcade N, et al. 1994 Bone loss after orthotopic liver transplantation. Am J Med. 97:445-450.
26. Lukert BP. 1995 Etidronate in the management of glucocorticoid-induced osteoporosis. Am J Med. 99:233-234.
27. Dempster DW. 1989 Perspectives: bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res. 4:137-141.
28. Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S. 1989 Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption. J Bone Miner Res. 4:393-398.
29. Schlosberg M, Movsowitz C, Epstein S, et al. 1989 The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat. Endocrinology. 124:2179-2184.
30. Movsowitz C, Epstein S, Fallon M, et al. 1988 Cyclosporin A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology. 123:2571-2577.
31. Cvetkovic M, Mann GN, Romero DF, et al. 1994 The deleterious effects of long term cyclosporin A, cyclosporin G and FK506 on bone mineral metabolism in vim. Transplantation. 57:1231-1237.
32. Aubia J, Masramon J, Serrano, Lloveras J, Marinoso L. 1988 Bone histology in renal transplant patients receiving cyclosporin. Lancet. 1:1048-1049.
33. Bourbigot B, Maol MC, Cleder J. 1988 Bone histology in renal transplant patients receiving cyclosporin. Lancet. 1:1048-1049.
34. Wilmink JM, Bras J, Surachno S, Heyst JLAM, Horst JM. 1989 Bone repair in cyclosporin treated renal transplant patients. Transplant Proc. 21:1492-1494.
35. Movsowitz C, Schlosberg M, Epstein S, et al. 1990 Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone. J Orthop Relat Res. 8:635-641.
36. Olivari MT, Antolick A, Kaye MP, Jamieson SW, Ring WS. 1988 Heart transplantation in elderly patients. J Heart Transplant. 7:258-264.
37. Sambrook PN, Kelly PJ, Fontana D, et al. 1994 Mechanics of rapid bone loss following cardiac transplantation. Osteopor Int. 4:273-276.
38. Henderson NK, Sambrook PN, Kelly PJ, et al. 1995 Bone mineral loss and recovery after cardiac transplantation. Lancet. 2:905.
39. Heroux AL, Costanzo-Nordin MR, O'Sullivan JE, et al. 1993 Heart transplantation as a treatment option for end-stage heart disease in patients older than 65 years of age. J Heart Lung Transplant. 12:573-579.
40. Ross PD, Davis JW, Epstein RS, Wasnich RD. 1991 Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 114:919-923.
41. Parisien MV, Dempster DW, Shane E, Silverberg SJ, Lindsay R, Bilezikian JP. 1990 Structural parameters of iliac bone biopsies in primary hyperparathyroidism. In: Takahashi HE, ed. Bone morphometry. Nigata, Japan: Nishimura; 228-231.
42. Reeve J, Meunier PJ, Parsons JA, et al. 1980 Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J. 280:1340-1344.
43. Reeve J, Arlot M, Bernat M, et al. 1980 Treatment of osteoporosis with human parathyroid hormone fragment 1-34: a positive final tissue balance in trabecular bone. Metab Bone Dis Rel Res. 25:355-360.
44. Slovik DM, Neer RM, Potts JT. 1981 Short-term effects of synthetic human parathyroid hormone (1-34) administration on bone mineral metabolism in osteoporotic patients. J Clin Invest. 68:1261-1271.
45. Slovik DM, Rosenthal DI, Doppelt SH, et al. 1986 Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25 dihydroxyvitamin D. J Bone Miner Res. 1:377-381.
46. Lindsay R, Cosman F, Nieves J, Dempster DW, Shen V. 1993 A controlled clinical trial of the effects of 1-34h PTH in estrogen treated osteoporotic women [Abstract]. J Bone Miner Res. 8:59.
47. Eriksen EF, Mosekilde L, Meisen F. 1986 Trabecular bone remodeling and balance in primary hyperparathyroidism. Bone. 7:213-221.
48. Parisien M, Silverberg SJ, Shane E, et al. 1990 The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab. 70:930-938.
49. Parisien M, Cosman F, Mellish RWR, et al. 1995 Bone structure in postmenopausal hyperparathyroid, osteoporotic and normal women. J Bone Miner Res. 10:1393-1399.
50. Julian BA, Laskow DA, Dubovsky J, et al. 1991 Rapid loss of vertebral bone density after renal transplantation. N Engl J Med. 325:544-550.
51. Horber FF, Casez JP, Steiger U, et al. 1994 Changes in bone mass early after kidney transplantation. J Bone Miner Res. 9:1-9.
52. Grotz WH, Mundinger FA, Gugel B, et al. 1994 Bone fracture and osteodensitometry with dual energy x-ray absorptiometry in kidney transplant recipients. Transplantation. 58:912-915.
53. Slatopolsky E, Delmez J. 1992 Bone disease in chronic renal failure and after renal transplantation. In: Coe FL, Favus MJ, eds. Disorders of bone and mineral metabolism. New York: Raven Press; 905-934.